Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | neuropeptide receptor A26 | 0.048 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.035 | 0.6999 | 1 |
Loa Loa (eye worm) | mucolipin 1 | 0.0068 | 0.0479 | 0.0684 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.035 | 0.6999 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.035 | 0.6999 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.035 | 0.6999 | 0.6848 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.033 | 0.6549 | 0.9324 |
Brugia malayi | Coelomocyte uptake defective protein 5 | 0.0068 | 0.0479 | 0.0684 |
Echinococcus multilocularis | neuropeptide s receptor | 0.048 | 1 | 1 |
Schistosoma mansoni | mucolipin | 0.0068 | 0.0479 | 0.0197 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.035 | 0.6999 | 1 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.035 | 0.6999 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.048 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.035 | 0.6999 | 0.6848 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0142 | 0.2191 | 1 |
Brugia malayi | kinase, mitochondrial precursor | 0.035 | 0.6999 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.033 | 0.6549 | 0.9324 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.035 | 0.6999 | 0.6848 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Agonistic activity against rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes; NA=inactive | ChEMBL. | 11141087 | |
Activity (functional) | Agonistic activity against rat Alpha3 beta4 Nicotinic Receptor expressed in Xenopus oocytes; NA=inactive | ChEMBL. | 11141087 | |
Activity (functional) | Agonistic activity against rat nicotinic acetylcholine receptor alpha7 expressed in Xenopus oocytes; NA=inactive | ChEMBL. | 11141087 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.